| DOXBX | VBINX | DOXBX / VBINX | |
| Total Expense Ratio | 0.42 | 0.18 | 233% |
| Annual Report Gross Expense Ratio | 0.48 | 0.18 | 267% |
| Fund Existence | 4 years | 34 years | - |
| Gain YTD | 2.837 | 4.938 | 57% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.8B | 64.1B | 23% |
| Annual Yield % from dividends | 2.48 | 1.89 | 131% |
| Returns for 1 year | 17.51 | 11.81 | 148% |
| Returns for 3 years | 108.00 | 31.28 | 345% |
| Returns for 5 years | N/A | 20.98 | - |
| Returns for 10 years | N/A | 99.59 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CMVYX | 17.57 | 0.20 | +1.15% |
| Columbia Select Mid Cap Value Instl 3 | |||
| FACSX | 56.32 | 0.54 | +0.97% |
| Nuveen Mid Cap Value Opportunities C | |||
| VADGX | 31.71 | 0.16 | +0.51% |
| Vanguard Advice Select Dividend Gr Admrl | |||
| ALLIX | 114.33 | -0.05 | -0.04% |
| AB Large Cap Growth I | |||
| HLHIX | 28.83 | -0.14 | -0.48% |
| Virtus KAR Health Sciences Inst | |||